Pasar al contenido principal

ESTUDIO DEL PAPEL DE LOS FACTORES DE CRECIMIENTO SIMILARES A LA INSULINA EN LA REGENERACION DE LA CELULA ß PANCREATICA

SAF2008-00962

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2008
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Gangarossa, Giuseppe
  • Santini, Emanuela
  • Fisone, Gilberto
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Food palatability produces behavioral modifications that resemble those induced by drugs of abuse. Palatability-induced behavioral changes require both, the activation of the endogenous cannabinoid system, and changes in structural plasticity in neurons of the brain reward pathway. The ERK intracellular pathway is activated by CB1 receptors (CB1-R) and plays a crucial role in neuroplasticity. We investigated the activation of the ERK signaling cascade in the mesocorticolimbic system induced by operant training to obtain highly palatable isocaloric food and the involvement of the CB1-R in these responses. Using immunofluorescence techniques, we analyzed changes in ERK intracellular pathway activation in the mesocorticolimbic system of wild-type and CB1 knockout mice (CB1-/-) trained on an operant paradigm to obtain standard, highly caloric or highly palatable isocaloric food. Operant training for highly palatable isocaloric food, but not for standard or highly caloric food, produced a robust activation of the ERK signaling cascade in the same brain areas where this training modified structural plasticity. These changes induced by the operant training were absent in CB1-/-. We can conclude that the activation of the ERK pathway is associated to the neuroplasticity induced by operant training for highly palatable isocaloric food and might be involved in CB1-R mediated alterations in behavior and structural plasticity., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and #SAF2008-00962), “Instituto de Salud Carlos III” (#RD06/001/001), “Plan Nacional sobre Drogas, the Catalan Government” (SGR2009-00131 and SGR 2009-224), the “ICREA Foundation” (ICREA Academia-2008), the “DG Research of the European Commission” (GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the “FIS” (PI07/0715), “ATIP-Avenir” and “Sanofi-Aventis” grants. This work was also supported by the “Plan Nacional Sobre Drogas” (#2009/026) to R.M
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Gangarossa, Giuseppe
  • Santini, Emanuela
  • Fisone, Gilberto
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Food palatability produces behavioral modifications that resemble those induced by drugs of abuse. Palatability-induced behavioral changes require both, the activation of the endogenous cannabinoid system, and changes in structural plasticity in neurons of the brain reward pathway. The ERK intracellular pathway is activated by CB1 receptors (CB1-R) and plays a crucial role in neuroplasticity. We investigated the activation of the ERK signaling cascade in the mesocorticolimbic system induced by operant training to obtain highly palatable isocaloric food and the involvement of the CB1-R in these responses. Using immunofluorescence techniques, we analyzed changes in ERK intracellular pathway activation in the mesocorticolimbic system of wild-type and CB1 knockout mice (CB1-/-) trained on an operant paradigm to obtain standard, highly caloric or highly palatable isocaloric food. Operant training for highly palatable isocaloric food, but not for standard or highly caloric food, produced a robust activation of the ERK signaling cascade in the same brain areas where this training modified structural plasticity. These changes induced by the operant training were absent in CB1-/-. We can conclude that the activation of the ERK pathway is associated to the neuroplasticity induced by operant training for highly palatable isocaloric food and might be involved in CB1-R mediated alterations in behavior and structural plasticity., This work was supported by the Spanish “Ministerio de Ciencia e Innovación” (#SAF2007-64062 and #SAF2008-00962), “Instituto de Salud Carlos III” (#RD06/001/001), “Plan Nacional sobre Drogas, the Catalan Government” (SGR2009-00131 and SGR 2009-224), the “ICREA Foundation” (ICREA Academia-2008), the “DG Research of the European Commission” (GENADDICT, #LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the “FIS” (PI07/0715), “ATIP-Avenir” and “Sanofi-Aventis” grants. This work was also supported by the “Plan Nacional Sobre Drogas” (#2009/026) to R.M
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Operant behavior to obtain palatable food modifies neuronal plasticity in the brain reward circuit

  • Guegan, Thomas, 1983-
  • Cutando Ruiz, Laura, 1985-
  • Ayuso, Eduard
  • Santini, Emanuela
  • Fisone, Gilberto
  • Bosch, Fatima
  • Martínez, Albert
  • Valjent, Emmanuel
  • Maldonado, Rafael, 1961-
  • Martín Sánchez, Miquel, 1971-
Palatability enhances food intake by hedonic mechanisms that prevail over caloric necessities. Different studies have demonstrated the role of endogenous cannabinoids in the mesocorticolimbic system in controlling food hedonic value and consumption. We hypothesize that the endogenous cannabinoid system could also be involved in the development of food-induced behavioral alterations, such as food-seeking and binge-eating, by a mechanism that requires neuroplastic changes in the brain reward pathway. For this purpose, we evaluated the role of the CB1 cannabinoid receptor (CB1-R) in the behavioral and neuroplastic changes induced by operant training for standard, highly caloric or highly palatable isocaloric food using different genetics, viral and pharmacological approaches. Neuroplasticity was evaluated by measuring changes in dendritic spine density in neurons previously labeled with the dye DiI. Only operant training to obtain highly palatable isocaloric food induced neuroplastic changes in neurons of the nucleus accumbens shell and prefrontal cortex that were associated to changes in food-seeking behavior. These behavioral and neuroplastic modifications induced by highly palatable isocaloric food were dependent on the activity of the CB1-R. Neuroplastic changes induced by highly palatable isocaloric food are similar to those produced by some drugs of abuse and may be crucial in the alteration of food-seeking behavior leading to overweight and obesity., This work was supported by the Spanish Ministerio de Ciencia e Innovació (#SAF2007-64062 and #SAF2008-00962), the Instituto de Salud CarlosIII (#RD06/001/001), the Plan Nacional sobre Drogas, the Catalan Government (SGR2009-00131 and SGR2009-224), the ICREA Foundation (ICREA Academia-2008), the DG Research of the European Commission (GENADDICT,/n#LSHM-CT-2004-05166; and PHECOMP, #LSHM-CT-2007-037669) the FIS’’ (PI07/0715),ATIP-Avenir and Sanofi-Aventis grants.This work was also supported by the Plan Nacional Sobre Drogas (#2009/026) to R.M.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Hypothalamic-specific manipulation of Fto , the ortholog of the human obesity gene FTO , affects food intake in rats

  • Tung, Yi-Chun Loraine
  • Ayuso, Eduard|||0000-0003-0811-2229
  • Shan, Xiaoye
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
  • O'Rahilly, Stephen
  • Coll, Anthony P.
  • Yeo, GS|||0000-0001-8823-3615
Sequence variants in the first intron of FTO are strongly associated with human obesity and human carriers of the risk alleles show evidence for increased appetite and food intake. Mice globally lacking Fto display a complex phenotype characterised by both increased energy expenditure and increased food intake. The site of action of FTO on energy balance is unclear. Fasting reduces levels of Fto mRNA in the arcuate nucleus (ARC) of the hypothalamus, a site where Fto expression is particularly high. In this study, we have extended this nutritional link by demonstrating that consumption of a high fat diet (45%) results in a 2.5 fold increase in Arc Fto expression. We have further explored the role of hypothalamic Fto in the control of food intake by using stereotactic injections coupled with AAV technology to bi-directionally modulate Fto expression. An over expression of Fto protein by 2.5-fold in the ARC results in a 14% decrease in average daily food intake in the first week. In contrast, knocking down Arc Fto expression by 40% increases food intake by 16%. mRNA levels of Agrp, Pomc and Npy, ARC-expressed genes classically associated with the control of food intake, were not affected by the manipulation of Fto expression. However, over expression of Fto resulted in a 4-fold increase in the mRNA levels of Stat3, a signalling molecule critical for leptin receptor signalling, suggesting a possible candidate for the mediation of Fto's actions. These data provide further support for the notion that FTO itself can influence key components of energy balance, and is therefore a strong candidate for the mediation of the robust association between FTO intronic variants and adiposity. Importantly, this provide the first indication that selective alteration of FTO levels in the hypothalamus can influence food intake, a finding consistent with the reported effects of FTO alleles on appetite and food intake in man.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Insulin-like growth factor 2 overexpression induces β-Cell dysfunction and increases beta-cell susceptibility to damage

  • Casellas Comallonga, Alba|||0000-0003-0203-4733
  • Mallol, Cristina|||0000-0002-2920-9612
  • Salavert Larrosa, Ariana
  • Jimenez, Veronica|||0000-0001-9145-9877
  • García Martínez, Miguel
  • Agudo, Judith|||0000-0002-3576-3169
  • Mercè Obach, Mercè
  • Haurigot Mendonça, Virginia|||0000-0002-9772-2565
  • Vilà Prats, Laia
  • Molas, Maria
  • Lage, Ricardo
  • Morró Larrubia, Meritxell|||0000-0003-1725-9599
  • Casaña Lorente, Estefania|||0000-0002-1353-5018
  • Ruberte Paris, Jesús|||0000-0003-1540-1432
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
The human insulin-like growth factor 2 (IGF2) and insulin genes are located within the same genomic region. Although human genomic studies have demonstrated associations between diabetes and the insulin/IGF2 locus or the IGF2 mRNA-binding protein 2 (IGF2BP2), the role of IGF2 in diabetes pathogenesis is not fully understood. We previously described that transgenic mice overexpressing IGF2 specifically in β-cells (Tg-IGF2) develop a pre-diabetic state. Here, we characterized the effects of IGF2 on β-cell functionality. Overexpression of IGF2 led to β-cell dedifferentiation and endoplasmic reticulum stress causing islet dysfunction in vivo. Both adenovirus-mediated overexpression of IGF2 and treatment of adult wild-type islets with recombinant IGF2 in vitro further confirmed the direct implication of IGF2 on β-cell dysfunction. Treatment of Tg-IGF2 mice with subdiabetogenic doses of streptozotocin or crossing these mice with a transgenic model of islet lymphocytic infiltration promoted the development of overt diabetes, suggesting that IGF2 makes islets more susceptible to β-cell damage and immune attack. These results indicate that increased local levels of IGF2 in pancreatic islets may predispose to the onset of diabetes. This study unravels an unprecedented role of IGF2 on β-cells function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toward a gene therapy for neurological and somatic MPSIIIA

  • Haurigot Mendonça, Virginia|||0000-0002-9772-2565
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Mucopolysaccharidosis Type IIIA (MPSIIIA) represents an unmet medical need. MPSIIIA shares with many other lysosomal storage disorders (LSD) the characteristic of being a severe neurodegenerative disease accompanied by mild somatic involvement. Thus, the main target organ for the development of new treatments is the central nervous system (CNS), but overall clinical efficacy would be greatly enhanced by simultaneous correction of peripheral disease. We have recently developed a novel treatment for MPSIIIA based on the delivery to the cerebrospinal fluid of serotype 9 adeno-associated virus (AAV9)-derived vectors. This gene therapy strategy corrected both CNS and somatic pathology in animal models through widespread transduction of CNS, peripheral nervous system (PNS), and liver. The work set the grounds for the clinical translation of the approach to treat MPSIIIA in humans. Here we discuss some important considerations that further support the applicability of this treatment to MPSIIIA and other LSD with CNS and somatic involvement.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nonviral-Mediated Hepatic Expression of IGF-I Increases Treg Levels and Suppresses Autoimmune Diabetes in Mice

  • Anguela, Xavier M.
  • Tafuro, Sabrina
  • Roca Lecha, Carles|||0000-0002-3744-3089
  • Callejas, David
  • Agudo, Judith|||0000-0002-3576-3169
  • Obach, Mercè|||0000-0002-2756-6181
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Ruzo, Albert
  • Mann, Christopher J.
  • Casellas Comallonga, Alba|||0000-0003-0203-4733
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
In type 1 diabetes, loss of tolerance to β-cell antigens results in T-cell-dependent autoimmune destruction of β cells. The abrogation of autoreactive T-cell responses is a prerequisite to achieve long-lasting correction of the disease. The liver has unique immunomodulatory properties and hepatic gene transfer results in tolerance induction and suppression of autoimmune diseases, in part by regulatory T-cell (Treg) activation. Hence, the liver could be manipulated to treat or prevent diabetes onset through expression of key genes. IGF-I may be an immunomodulatory candidate because it prevents autoimmune diabetes when expressed in β cells or subcutaneously injected. Here, we demonstrate that transient, plasmid-derived IGF-I expression in mouse liver suppressed autoimmune diabetes progression. Suppression was associated with decreased islet inflammation and β-cell apoptosis, increased β-cell replication, and normalized β-cell mass. Permanent protection depended on exogenous IGF-I expression in liver nonparenchymal cells and was associated with increased percentage of intrapancreatic Tregs. Importantly, Treg depletion completely abolished IGF-I-mediated protection confirming the therapeutic potential of these cells in autoimmune diabetes. This study demonstrates that a nonviral gene therapy combining the immunological properties of the liver and IGF-I could be beneficial in the treatment of the disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance

  • Elias Puigdomenech, Ivet|||0000-0002-1304-9597
  • Franckhauser, Sylvie|||0000-0001-5255-1224
  • Bosch i Tubert, Fàtima|||0000-0002-7705-5515
Vascular endothelial growth factor A (VEGF-A) is classically viewed as a key factor in angiogenesis and tissue remodeling. However, recent evidence suggests a potential role of this growth factor in the control of energy metabolism and adipose tissue function. In this regard, we and others have described the effects of the up and downregulation of VEGF-A in adipose tissue on the control of energy homeostasis. VEGF-A overexpression protects against diet-induced obesity and insulin resistance. The observation that VEGF-A overexpression leads to an increase in brown adipose tissue (BAT) thermogenesis and also promotes a "BAT-like" phenotype in white adipose tissue depots is of particular relevance for the understanding of the mechanisms underlying obesity development. In addition, VEGF-A may not only have pro-inflammatory but also anti-inflammatory properties, with a chemotactic activity specific for M2 anti-inflammatory macrophages. This new scientific evidence highlights the importance that VEGF-A actions on metabolism could have on the design of new treatments for obesity, insulin resistance and obesity-related disorders.